CAS: 2343-27-3; (2-Fluorophenyl)Glycine

该化合物是一种有机化合物,其特征是,在苯环上,特别是在与甘油氨基酸结构相对的正方形位置上,存在一个氟原子,具体而言,这种化合物具有芳香环和氨基酸功能组,有助于其潜在的生物活动,通常看起来像白色的白色和非白色的固体,由于氨基化合物的存在,极地溶剂中可溶解.氟替代物可影响该化合物的电子特性,可能影响其再活动性和与生物目标的相互作用.(2-氟联苯)甘油对医药化学和研究感兴趣,特别是在药物开发方面,因为对氨基酸的修改可导致增加功效或改变药用植物遗传学的化合物.其合成通常涉及标准的有机反应,包括核糖替代和混合反应,使之可用于化学研究和药物开发的各种应用.

结构式图片

欧盟法规

C&L通报

上下游产品

benzylamino-(2-fluoro-phenyl)-acetic acid 2-Fluorobenzaldehyde Benzylamino-(2-fluoro-phenyl)-acetonitrile 2-benzylamino-2-(2-fluoro-phenyl)-acetamide

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2023037284-A9
    优先权日:2018-11-30
    标题:Combination therapy of peptidomimetic macrocycles
    发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-2025084410-A1
    优先权日:2015-01-12
    标 题:Incorporation of unnatural nucleotides and methods thereof
    发明人:PTACIN JEROD; MALYSHEV DENIS A; CAFFARO CAROLINA E
    权利人:SYNTHORX INC
    摘要:Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

    专利号:US-2018371021-A1
    优先权日:2017-05-11
    标 题 :Peptidomimetic macrocycles and uses thereof
    发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-5892038-A
    优先权日:1997-12-08
    标 题 :Hydroxy-amino acid amides
    发明人:DOLLE III ROLAND ELLWOOD; PATEL HITESH K
    权利人:PHARMACOPEIA INC
    摘要:Compounds of Formula I I are disclosed as inhibitors of plasmepsin and cathepsin D. The compounds are therefore useful to treat diseases such as malaria. In preferred compounds of formula I, Y is the residue of an N-acylated amino acid, a substituted 4-aminoproline or a substituted piperazinealkanoic acid. Intermediates in the solid phase synthesis of compounds of formula I, in which the compounds are attached to a solid support, are also disclosed.

    专利号:CA-3153855-A1
    优先权日:2019-10-10
    标题:Compositions and methods for in vivo synthesis of unnatural polypeptides

    专利号:US-5872262-A
    优先权日:1996-11-05
    标 题:Hydroxy-amino acid amides
    发明人:DOLLE ROLAND ELLWOOD III; JOHNSON THEODORE O JR; TAO SHIWEI
    权利人:PHARMACOPEIA INC
    摘要:Compounds of Formula I I are disclosed as inhibitors of plasmepsin and cathepsin D. The compounds are therefore useful to treat diseases such as malaria. In preferred compounds of formula I, Y is the residue of an N-acylated amino acid, a substituted 4-aminoproline or a substituted piperazinealkanoic acid. Intermediates in the solid phase synthesis of compounds of formula I, in which the compounds are attached to a solid support, are also disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1038/s41430-022-01112-7
    摘要:Lawrence WR, Lim J, Huang J, Sampson JN, Weinstein SJ, Albanes D. Metabolomic analysis of serum alpha-tocopherol among men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. European Journal of Clinical Nutrition. 2022 Mar 23;76(9):1254–65. doi: 10.1038/s41430-022-01112-7.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知